S 2005119th CongressIntroduced

IDeA Reauthorization Act of 2025

Introduced: Jun 10, 2025

Healthcare

Standard Summary

Comprehensive overview in 1-2 paragraphs

The IDeA Reauthorization Act of 2025 reauthorizes and strengthens the Institutional Development Award (IDeA) program within the National Institutes of Health (NIH). The bill clarifies the program’s naming, defines which states qualify as IDeA States (those with state-level NIH funding for biomedical/behavioral research that is at or below the national median when calculated on a rolling multi-year average, excluding IDeA funds), and requires new annual reporting to Congress and to the public. The reporting would cover the program’s strategy and objectives, recent awards and integration with NIH initiatives, the share of program reviewers from IDeA States, large collaboration awards between IDeA and non-IDeA institutions, and gains in research quality and workforce development over the prior five fiscal years. The intent is to promote transparency, accountability, and systematic investment in biomedical research capacity in states with historically lower NIH funding.

Key Points

1Renames the program and tightens eligibility: The IDeA program is explicitly named and defined to cover entities conducting biomedical or behavioral research located in states with NIH funding levels at or below the national median, using a rolling multi-year average (excluding IDeA funding) to determine eligibility.
2Adds annual, public reporting requirements: NIH must provide Congress, as part of the federal budget submission, or via a publicly accessible annual data source, details on the program’s strategy and objectives.
3Requires recent awards data and integration efforts: The annual reporting must include descriptions of awards in the previous fiscal year, efforts to integrate IDeA States into major NIH activities, the percentage of IDeA program reviewers from IDeA States, and updates on large collaboration awards involving IDeA and non-IDeA institutions.
4Emphasizes outcomes and capacity building: The report must describe gains in academic research quality and biomedical science human resource development achieved by the IDeA program over the last five fiscal years.
5Sponsors and status: Introduced in the Senate (S. 2005) by Senators Hyde-Smith, Capito, and Hassan; status is “Introduced”—no passage yet.

Impact Areas

Primary group/area affected- Institutions and researchers located in IDeA States (states with lower historical NIH funding) that participate in or seek NIH funding through the IDeA program.- NIH program leadership and staff responsible for administering the IDeA program and producing annual reports.Secondary group/area affected- Researchers and institutions in non-IDeA States involved in collaborations with IDeA States, due to requirements for reporting on large collaborator awards and integration efforts.- NIH reviewers, specifically the share of reviewers from IDeA States, which the bill would highlight and potentially influence.Additional impacts- Transparency and accountability: Public and Congressional access to strategic objectives, outcomes, and collaboration activity may influence program design and funding decisions.- Budget and reporting burden: NIH would incur new reporting obligations and data management to maintain public datasets and budget submissions.- Policy impetus: Strengthened emphasis on capacity-building in lower-funded states could shift future NIH investment strategies and regional research development.

Generated by gpt-5-nano on Oct 3, 2025